Multicentre comparative study of neural epidermal growth factor-like 1 protein <i>vs</i> M-type phospholipase A2 receptor-associated membranous nephropathy. [PDF]
World J NephrolSathiavageesan S +3 more
europepmc +1 more source
Migrasomes in kidney diseases: emerging molecular mechanisms, diagnostic value, and therapeutic prospects. [PDF]
Biochem Soc TransQin W, Li B, Zhang Y, Nie P.
europepmc +1 more source
This study investigated the clinical and laboratory characteristics of immune system disorders and endothelial dysfunction in patients with chronic glomerulonephritis (CG).
Abdujalilovna, T. D. (Tojiboyeva) +1 more
core
CD38-targeted therapies in kidney disease: evidence maturity, disease-stage dependence, and biomarker-guided retreatment. [PDF]
Front Med (Lausanne)Feng P, Yu X.
europepmc +1 more source
The BAFF/APRIL system in autoimmune nephropathy: from pathogenesis to targeted biologic therapies. [PDF]
Front Med (Lausanne)Jia Y +5 more
europepmc +1 more source
Anti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous Nephropathy2016年度
openaire +1 more source
Ten tips for the diagnosis and management of nephrotic syndrome. [PDF]
Clin Kidney JBerke I +9 more
europepmc +1 more source
Efficacy and safety of obinutuzumab in patients with primary membranous nephropathy: a focus on refractory and rituximab-resistant patients. [PDF]
Front ImmunolGao Q, Yao G, Sun Y, Li X, Li Z, Chen B.
europepmc +1 more source
Quantitative serological detection of NELL1 autoantibodies in membranous nephropathy. [PDF]
Kidney IntBurbelo PD +6 more
europepmc +1 more source